Willingness to Pay for a Treatment for Pain in Multiple Sclerosis

Author： Iskedjian Michael   Desjardins Olivier  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.2, 2009-01, pp. : 149-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs Treatment of Pain in Multiple Sclerosis

By  

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain

By Tanasescu Radu   Constantinescu Cris S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1219-1228

Informa Healthcare

Access to resources Recommend Favorite

Willingness to Pay for Lung Cancer Treatment

By Lang Hui-Chu  

Value in Health, Vol. 13, Iss. 6, 2010-09 ,pp. : 743-749

Blackwell Publishing

Access to resources Recommend Favorite

Treating pain in multiple sclerosis

By Truini Andrea   Galeotti Francesca   Cruccu Giorgio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2355-2368

Informa Healthcare

Access to resources Recommend Favorite

Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

By Barnes Michael Philip  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 607-615

Informa Healthcare

Access to resources Recommend Favorite